p27 Kip1 Antibodies

Santa Cruz Biotechnology features a diverse variety of p27 Kip1 monoclonal antibodies for research in cell cycle regulation and cancer biology. The monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). p27 Kip1 is a critical cyclin-dependent kinase inhibitor that plays a vital role in regulating the cell cycle by inhibiting cyclin-CDK complexes, thereby controlling cell proliferation. p27 Kip1 dysregulation is often associated with various cancers, making it an important biomarker for tumor progression and a potential target for therapeutic intervention. Understanding p27 Kip1 function and regulation is essential for advancing cancer research and developing new treatment strategies. Researchers can explore p27 Kip1's role in cell cycle checkpoints and its impact on cellular differentiation. p27 Kip1 studies have revealed significant insights into tumor suppression mechanisms and cell growth control. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cell cycle regulation and cancer biology.